Patents by Inventor Felix Sebastian Kaechele

Felix Sebastian Kaechele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230379256
    Abstract: In one embodiment, a device obtains path probing data for paths between a set of network nodes wherein a first subset of the set of network nodes are operated by a provider of an online application or service and a second subset of the set of network nodes operated by affiliates. The device generates, based on the path probing data, a performance model of path performances between clients in different geolocations and the online application or service via each of the set of network nodes. The device determines, based on the performance model, a particular node in the second subset should be used as a point of presence for clients located in a particular one of the different geolocations to access the online application or service. The device configures a network overlay including the first subset and the particular node as points of presence for the online application or service.
    Type: Application
    Filed: May 18, 2022
    Publication date: November 23, 2023
    Inventors: Cody Hartsook, John Parello, Tirthankar Ghose, Giles Douglas Yorke Heron, Felix Sebastian Kaechele
  • Patent number: 11475451
    Abstract: A mobile device is provided that includes biometric sensor(s), and a processor that causes the biometric sensor(s) to acquire a physiological marker of a user, and identify and authenticate the user. The processor sends a message to an authentication server that indicates the user is authenticated, and receives a response from the authentication server that includes a unique authentication code. The processor receives selection of a thereby selected over-the-counter (OTC) drug, and communicates with a point-of-sale (POS) system with contactless payment capability. The processor sends a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information. And the POS system communicates with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: October 18, 2022
    Assignee: Bayer Healthcare LLC
    Inventors: Goeran M. Jerstroem, Michael DeBiasi, Felix Sebastian Kaechele
  • Publication number: 20180285880
    Abstract: A mobile device is provided that includes biometric sensor(s), and a processor that causes the biometric sensor(s) to acquire a physiological marker of a user, and identify and authenticate the user. The processor sends a message to an authentication server that indicates the user is authenticated, and receives a response from the authentication server that includes a unique authentication code. The processor receives selection of a thereby selected over-the-counter (OTC) drug, and communicates with a point-of-sale (POS) system with contactless payment capability. The processor sends a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information. And the POS system communicates with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.
    Type: Application
    Filed: March 27, 2018
    Publication date: October 4, 2018
    Inventors: Goeran M. Jerstroem, Michael DeBiasi, Felix Sebastian Kaechele